{"id":"https://openalex.org/W2186390845","doi":null,"title":"PSYCHOTROPIC INTERACTIONS OF SOME ANTI-HYPERTENSIVES IN MALE ALBINO RATS AND MICE","display_name":"PSYCHOTROPIC INTERACTIONS OF SOME ANTI-HYPERTENSIVES IN MALE ALBINO RATS AND MICE","publication_year":2008,"publication_date":"2008-01-01","ids":{"openalex":"https://openalex.org/W2186390845","mag":"2186390845"},"language":"en","primary_location":{"id":"mag:2186390845","doi":null,"is_oa":false,"landing_page_url":"https://pharmacologyonline.silae.it/files/archives/2008/vol3/085_Vivek.pdf","pdf_url":null,"source":null,"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":null},"volume":null,"type":"article","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5076285276","display_name":"Vivek Vivek","orcid":"https://orcid.org/0000-0002-5686-0961","observed_orcids":["https://orcid.org/0000-0002-5686-0961"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Vivek Vivek","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5010866414","display_name":"Patil Pa","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Patil Pa","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11071","display_name":"Treatment of Major Depression","score":0.7523999810218811,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11071","display_name":"Treatment of Major Depression","score":0.7523999810218811,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":0.10589999705553055,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10144","display_name":"Blood Pressure and Hypertension Studies","score":0.030799999833106995,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/psychotropic-effects","display_name":"psychotropic effects","score":0.5730000138282776},{"id":"https://openalex.org/keywords/antihypertensive-drugs","display_name":"antihypertensive drugs","score":0.9160000085830688},{"id":"https://openalex.org/keywords/prazosin","display_name":"prazosin","score":0.9599999785423279},{"id":"https://openalex.org/keywords/propranolol","display_name":"propranolol","score":1.0},{"id":"https://openalex.org/keywords/losartan","display_name":"losartan","score":1.0},{"id":"https://openalex.org/keywords/venlafaxine","display_name":"venlafaxine","score":0.9990000128746033},{"id":"https://openalex.org/keywords/antidepressant-effects","display_name":"antidepressant effects","score":0.9589999914169312},{"id":"https://openalex.org/keywords/anxiolytic-effects","display_name":"anxiolytic effects","score":1.0},{"id":"https://openalex.org/keywords/drug-interactions","display_name":"drug interactions","score":0.703000009059906},{"id":"https://openalex.org/keywords/depression","display_name":"depression","score":0.9390000104904175},{"id":"https://openalex.org/keywords/anxiety","display_name":"anxiety","score":0.9729999899864197},{"id":"https://openalex.org/keywords/forced-swim-test","display_name":"forced swim test","score":0.7990000247955322},{"id":"https://openalex.org/keywords/tail-suspension-test","display_name":"tail suspension test","score":0.9929999709129333},{"id":"https://openalex.org/keywords/elevated-plus-maze","display_name":"elevated plus maze","score":0.9580000042915344},{"id":"https://openalex.org/keywords/light-dark-box-test","display_name":"light-dark box","score":0.48399999737739563},{"id":"https://openalex.org/keywords/comorbidity","display_name":"comorbidities","score":0.640999972820282}],"concepts":[{"id":"https://openalex.org/C2780648677","wikidata":"https://www.wikidata.org/wiki/Q425296","display_name":"Prazosin","level":4,"score":0.8292336463928223},{"id":"https://openalex.org/C2777765862","wikidata":"https://www.wikidata.org/wiki/Q62903","display_name":"Anxiolytic","level":3,"score":0.7697051167488098},{"id":"https://openalex.org/C2781001258","wikidata":"https://www.wikidata.org/wiki/Q7676084","display_name":"Tail suspension test","level":5,"score":0.7382684350013733},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.6966208219528198},{"id":"https://openalex.org/C2776466888","wikidata":"https://www.wikidata.org/wiki/Q898407","display_name":"Venlafaxine","level":4,"score":0.6684712171554565},{"id":"https://openalex.org/C2779177272","wikidata":"https://www.wikidata.org/wiki/Q76560","display_name":"Antidepressant","level":3,"score":0.6631989479064941},{"id":"https://openalex.org/C2778151854","wikidata":"https://www.wikidata.org/wiki/Q423364","display_name":"Propranolol","level":2,"score":0.6586565971374512},{"id":"https://openalex.org/C2780288358","wikidata":"https://www.wikidata.org/wiki/Q410074","display_name":"Losartan","level":4,"score":0.5238897204399109},{"id":"https://openalex.org/C136569192","wikidata":"https://www.wikidata.org/wiki/Q4880745","display_name":"Behavioural despair test","level":4,"score":0.5061103701591492},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.45472589135169983},{"id":"https://openalex.org/C558461103","wikidata":"https://www.wikidata.org/wiki/Q154430","display_name":"Anxiety","level":2,"score":0.3232784867286682},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.28885266184806824},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.17229175567626953},{"id":"https://openalex.org/C2908929049","wikidata":"https://www.wikidata.org/wiki/Q65963433","display_name":"Angiotensin II","level":3,"score":0.10744684934616089},{"id":"https://openalex.org/C2776885963","wikidata":"https://www.wikidata.org/wiki/Q245204","display_name":"Antagonist","level":3,"score":0.10444080829620361},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.06527337431907654}],"mesh":[],"locations_count":1,"locations":[{"id":"mag:2186390845","doi":null,"is_oa":false,"landing_page_url":"https://pharmacologyonline.silae.it/files/archives/2008/vol3/085_Vivek.pdf","pdf_url":null,"source":null,"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":25,"referenced_works":["https://openalex.org/W294850229","https://openalex.org/W1483429021","https://openalex.org/W1771441866","https://openalex.org/W1967685853","https://openalex.org/W1989081738","https://openalex.org/W2005594217","https://openalex.org/W2018946923","https://openalex.org/W2027120048","https://openalex.org/W2027298872","https://openalex.org/W2027397526","https://openalex.org/W2028342787","https://openalex.org/W2028594226","https://openalex.org/W2041561931","https://openalex.org/W2045551092","https://openalex.org/W2045980664","https://openalex.org/W2074016011","https://openalex.org/W2074133854","https://openalex.org/W2081718042","https://openalex.org/W2083572688","https://openalex.org/W2089299823","https://openalex.org/W2133144591","https://openalex.org/W2213544100","https://openalex.org/W2325022794","https://openalex.org/W2397112312","https://openalex.org/W2415264954"],"related_works":["https://openalex.org/W1483429021","https://openalex.org/W2896542585","https://openalex.org/W2409956434","https://openalex.org/W8911048","https://openalex.org/W4312126878","https://openalex.org/W96149003","https://openalex.org/W2101371237","https://openalex.org/W1973884237","https://openalex.org/W2021565043","https://openalex.org/W2082332424"],"abstract_inverted_index":{"Summary":[0],"The":[1,30],"psychotropic":[2,21,115],"activities":[3,34,116],"of":[4,23,83,117],"commonly":[5],"prescribed":[6],"antihypertensives":[7,25,90,113],"prazosin,":[8],"propranolol":[9,102,109],"and":[10,32,41,51,59,103,108],"losartan":[11,60,107],"are":[12,16],"controversial.":[13],"Also":[14],"there":[15],"scanty":[17],"reports":[18],"on":[19],"the":[20,89,93],"interaction":[22,79],"these":[24],"with":[26],"an":[27],"antidepressant-anxiolytic,":[28],"venlafaxine.":[29],"antidepressant":[31,63,96],"anxiolytic":[33,67,73,81],"were":[35],"elicited":[36],"using":[37],"forced":[38],"swim":[39],"test":[40,44],"tail":[42],"suspension":[43],"paradigms":[45,55],"for":[46,56],"depression;":[47],"elevated":[48],"plus":[49],"maze":[50],"light":[52],"dark":[53],"arena":[54],"anxiety.":[57],"Propranolol":[58],"showed":[61,72],"significant":[62],"as":[64,66],"well":[65],"activity,":[68,74],"while":[69,95],"prazosin":[70],"though":[71],"significantly":[75],"induced":[76],"depression.":[77],"In":[78,105],"studies":[80],"activity":[82,97],"venlafaxine":[84],"was":[85,98],"potentiated":[86,100],"by":[87,101],"all":[88],"used":[91],"in":[92,124],"study,":[94],"only":[99],"losartan.":[104],"conclusion":[106],"appears":[110],"to":[111],"be":[112,121],"potentiating":[114],"venlafaxine,":[118],"thus":[119],"may":[120],"effective":[122],"combination":[123],"comorbid":[125],"condition.":[126]},"counts_by_year":[],"updated_date":"2026-11-08T12:12:28.789561","created_date":"2016-06-24T00:00:00"}